Yoo, Changhoon
Lee, Sang Soo
Song, Ki Byung
Jeong, Jae Ho
Hyung, Jaewon
Park, Do Hyun
Song, Tae Jun
Seo, Dong Wan
Lee, Sung Koo
Kim, Myung-Hwan
Lee, Seung Soo
Kim, Jin Hee
Jin, Hyung-seung
Park, Jin-hong
Hwang, Dae Wook
Lee, Jae Hoon
Lee, Woohyung
Chang, Heung-Moon
Kim, Kyu-pyo
Ryoo, Baek-Yeol
Kim, Song Cheol
Funding for this research was provided by:
MSIP | Institute for Information and communications Technology Promotion (NRF- 2016M3A9E8941331)
Asan Institute for Life Sciences, Asan Medical Center (2016-728)
Ministry of Health and Welfare (HI14C2640)
Article History
Received: 13 March 2020
Revised: 2 April 2020
Accepted: 16 April 2020
First Online: 20 May 2020
Ethics approval and consent to participate
: The study was approved by the Institutional Review Board of Asan Medical Center, Seoul, Korea (approval number: 2016-0010) and conducted in accordance with the Declaration of Helsinki and Good Clinical Practice. All patients provided written informed consent before enrolment.
: Not applicable.
: The data that support the findings of this study are available from the corresponding author upon reasonable request.
: The authors declare no competing interests.
: This study was supported in part by Boryung Pharmaceutical Co., Ltd, the Bio and Medical Technology Development Program from the National Research Foundation (NRF) that is funded by Korean Ministry of Science, Communications Technology, and Future Planning (MSIP) (NRF-2016M3A9E8941331), the Korean Health Technology R&D Project, Ministry of Health & Welfare (HI14C2640), and a grant (2016-728) from the Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea. The funding sources had no role in study design, collection and analysis of data, or writing of the report.